Market By Drug Type, Technology, Service, End-user, And Geography | Forecast 2019-2028
According to Triton Market Research, the drug discovery market in the Middle East and Africa is expected to grow exponentially at a CAGR of 5.71% for the forecasting phase of 2019-2028.
Report scope can be customized per your requirements. Request For Customization
Following are the countries that are included in the drug discovery
market analysis of the Middle East and Africa region:
• Saudi Arabia
• Turkey
• The United Arab
Emirates
• South Africa
• Rest of MEA countries
The drug discovery market in
the region is driven primarily by government initiatives to propel growth in
scientific research. For instance, South Africa’s Biomedical Translational
Research Initiative (BTRI) was initiated by the University of Cape Town (UCT)
and the CSIR (Council of Scientific and Industrial Research) for biomedical
research. The main goal of the initiative is to bring various institutes to
join hands to develop translational research. This is expected to increase the
research activities in the country, which, in turn, will further boost the drug
discovery process. This will benefit the studied market in the Middle East and
Africa.
The high pervasiveness of
acute & chronic diseases and the rising healthcare expenses are the factors
fueling the growth of Saudi Arabia’s drug discovery market. The concept of drug
discovery encompasses all the costs incurred by a drug discovery company. For
effectively executing the process of drug discovery, the cost of hardware and
software is considerably high. Here, the overall expenditure on research and
development is low. Hence, the funding available to each company in the market
is far lesser than that available in the developed regions. This might
negatively impact the market growth. However, the high prevalence of chronic
diseases in the nation is creating the demand for novel drug development for
the treatment of diseases. This is one of the driving forces of the KSA drug
discovery market during the forecast period.
Becton Dickinson, and Company (BD) is a renowned med-tech company. It develops, manufactures, and sells medical devices, diagnostic products, and laboratory equipment. The company’s major products include syringes & pen needles, IV catheters, infusion pumps & disposables, respiratory ventilation & diagnostics equipment, automated medication dispensing systems, diagnostics specimens, and instruments to detect a broad range of infectious diseases, HAIs, and cancer. The company offers its products to clinical laboratories, healthcare institutions, life science researchers, the pharma industry, and the general public. BD has a notable presence in the Middle East and Africa.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA DRUG DISCOVERY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER'S
FIVE FORCES MODEL
2.2.1. THREATS
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. COVID-19
AND ITS IMPACT ON DRUG DISCOVERY MARKET
2.4. PESTLE
OUTLOOK
2.5. REGULATORY
FRAMEWORK
2.6. VALUE
CHAIN OUTLOOK
2.7. MARKET
ATTRACTIVENESS INDEX
2.8. KEY
INSIGHT
2.9. MARKET
DRIVERS
2.9.1. GROWING
AGED POPULATION
2.9.2. TECHNOLOGICAL
ADVANCEMENTS
2.9.3. RISE
IN HEALTHCARE EXPENDITURE
2.9.4. SURGE
IN LIFESTYLE-ORIENTED DISEASES
2.10. MARKET RESTRAINTS
2.10.1. DELAY IN PRODUCT LAUNCHES
2.10.2. RESTRICTED GROWTH RATE DUE TO GENERIC DRUGS
2.11. MARKET OPPORTUNITIES
2.11.1. SIGNIFICANT INVESTMENT BY HEALTHCARE INDUSTRIES
IN IMPROVING BIG DATA ANALYTICAL CAPABILITIES
2.11.2. RISING DEMAND FOR SPECIALTY MEDICINES
2.12. MARKET CHALLENGES
2.12.1. POOR REIMBURSEMENTS POLICIES IN EMERGING
NATIONS
2.12.2. STRINGENT GOVERNMENT REGULATIONS
3. DRUG
DISCOVERY MARKET OUTLOOK - BY DRUG TYPE
3.1. SMALL
MOLECULE DRUG
3.2. BIOLOGIC
DRUG
4. DRUG
DISCOVERY MARKET OUTLOOK - BY TECHNOLOGY
4.1. HIGH
THROUGHPUT SCREENING
4.2. BIOCHIPS
4.3. BIOINFORMATICS
4.4. PHARMACOGENOMICS
AND PHARMACOGENETICS
4.5. COMBINATORIAL
CHEMISTRY
4.6. NANOTECHNOLOGY
4.7. SPECTROSCOPY
4.8. METABOLOMICS
4.9. OTHER
TECHNOLOGIES
5. DRUG
DISCOVERY MARKET OUTLOOK - BY SERVICE
5.1. DRUG
METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
5.2. CHEMICAL
SERVICES
5.3. BIOLOGICAL
SERVICES
5.4. OTHER
PHARMACEUTICAL SERVICES
6. DRUG
DISCOVERY MARKET OUTLOOK - BY END-USER
6.1. RESEARCH
INSTITUTES
6.2. PHARMACEUTICAL
COMPANIES
6.3. CONTRACT
RESEARCH ORGANIZATIONS (CROS)
6.4. OTHER
END-USERS
7. DRUG
DISCOVERY MARKET – MIDDLE EAST AND AFRICA
7.1. COUNTRY
ANALYSIS
7.1.1. SAUDI
ARABIA
7.1.2. TURKEY
7.1.3. UNITED
ARAB EMIRATES
7.1.4. SOUTH
AFRICA
7.1.5. REST
OF MIDDLE EAST AND AFRICA
8. COMPANY
PROFILES
8.1. 3M
COMPANY
8.2. ABBOTT
LABORATORIES INC
8.3. AGILENT
TECHNOLOGIES INC
8.4. ANTARES
PHARMA INC
8.5. ASTRAZENECA
PLC
8.6. BAYER
AG
8.7. BECTON
DICKINSON & COMPANY (BD)
8.8. BOEHRINGER
INGELHEIM
8.9. ELI
LILY AND COMPANY
8.10. F HOFFMANN-LA ROCHE LTD
8.11. GLAXOSMITHKLINE LLC
8.12. JOHNSON & JOHNSON
8.13. MERCK & CO INC
8.14. NOVARTIS
8.15. PFIZER INC
8.16. SANOFI
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY COUNTRY,
2019-2028 ($ MILLION)
TABLE 2 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY TECHNOLOGY,
2019-2028 ($ MILLION)
TABLE 3 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY DRUG TYPE,
2019-2028 ($ MILLION)
TABLE 4 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY SERVICE,
2019-2028 ($ MILLION)
TABLE 5 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY END-USER,
2019-2028 ($ MILLION)
TABLE 6 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)
FIGURE 1 MIDDLE EAST AND AFRICA DRUG DISCOVERY
MARKET, BY REGION, 2019-2028 ($ MILLION)
FIGURE 2 MIDDLE EAST AND AFRICA DRUG DISCOVERY
MARKET, BY SMALL MOLECULE DRUG, 2019-2028 ($ MILLION)
FIGURE 3 MIDDLE EAST AND AFRICA DRUG DISCOVERY
MARKET, BY BIOLOGIC DRUG, 2019-2028 ($ MILLION)
FIGURE 4 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET,
BY HIGH THROUGHPUT SCREENING, 2019-2028 ($ MILLION)
FIGURE 5 MIDDLE EAST AND AFRICA DRUG DISCOVERY
MARKET, BY BIOCHIPS, 2019-2028 ($ MILLION)
FIGURE 6 MIDDLE EAST AND AFRICA DRUG DISCOVERY
MARKET, BY BIOINFORMATICS, 2019-2028 ($ MILLION)
FIGURE 7 MIDDLE EAST AND AFRICA DRUG DISCOVERY
MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2028 ($ MILLION)
FIGURE 8 MIDDLE EAST AND AFRICA DRUG DISCOVERY
MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2028 ($ MILLION)
FIGURE 9 MIDDLE EAST AND AFRICA DRUG DISCOVERY
MARKET, BY NANOTECHNOLOGY, 2019-2028 ($ MILLION)
FIGURE 10 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET,
BY SPECTROSCOPY, 2019-2028 ($ MILLION)
FIGURE 11 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET,
BY METABOLOMICS, 2019-2028 ($ MILLION)
FIGURE 12 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET,
BY OTHER TECHNOLOGIES, 2019-2028 ($ MILLION)
FIGURE 13 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET,
BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2028 ($ MILLION)
FIGURE 14 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET,
BY CHEMICAL SERVICES, 2019-2028 ($ MILLION)
FIGURE 15 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET,
BY BIOLOGICAL SERVICES, 2019-2028 ($ MILLION)
FIGURE 16 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET,
BY OTHER PHARMACEUTICAL SERVICES, 2019-2028 ($ MILLION)
FIGURE 17 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET,
BY RESEARCH INSTITUTES, 2019-2028 ($ MILLION)
FIGURE 18 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET,
BY PHARMACEUTICAL COMPANIES, 2019-2028 ($ MILLION)
FIGURE 19 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET,
BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2028 ($ MILLION)
FIGURE 20 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET,
BY OTHER END-USERS, 2019-2028 ($ MILLION)
FIGURE 21 SAUDI ARABIA DRUG DISCOVERY MARKET 2019-2028
($ MILLION)
FIGURE 22 TURKEY DRUG DISCOVERY MARKET 2019-2028 ($
MILLION)
FIGURE 23 UNITED ARAB EMIRATES DRUG DISCOVERY MARKET
2019-2028 ($ MILLION)
FIGURE 24 SOUTH AFRICA DRUG DISCOVERY MARKET 2019-2028
($ MILLION)
FIGURE 25 REST OF MIDDLE EAST AND AFRICA DRUG DISCOVERY
MARKET 2019-2028 ($ MILLION)